Ibuprofen lysine

布洛芬赖氨酸

Report date: 2026/03/30 17:02:26

Base Information

Drug NameIbuprofen lysine
Drug Alias NameIbuprofen lysinate赖氨洛芬布洛芬赖氨酸盐NeoProfenSJP-0129
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsHeadachePainDuctus Arteriosus, Patent +[4] 
Global Approved IndicationsHeadacheDuctus Arteriosus, PatentMigraine Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited Kingdom
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomEU +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesRecordati Rare Diseases IncTakeda Pharmaceutical Co LtdReckitt Benckiser Healthcare (Uk) Ltd +[4] 
Inactive CompaniesFarmacon
Active IndicationsHeadachePainDuctus Arteriosus, Patent +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeC01EB16G02CC01M01AE01 +[5] 
Related LinksWikipediaDrugBankKEGG